Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S)-17-((1H-imidazol-5-yl)methyl)-41-((S)-6-amino-2-((S)-6-amino-2-((S)-2-((S)-1-((6S,9S,12S,18S,21S,24S)-1,6-diamino-21-(3-amino-3-oxopropyl)-9-(carboxymethyl)-24-(3-guanidinopropyl)-18-(hydroxymethyl)-1-imino-12-methyl-7,10,13,16,19,22-hexaoxo-2,8,11,14,17,20,23-heptaazapentacosane)pyrrolidine-2-carboxamido)-5-guanidinopentanamido)hexanamido)hexanamido)-35-(2-amino-2-oxoethyl)-11-(4-aminobutyl)-14,23-bis(2-carboxyethyl)-38-(carboxymethyl)-8,20-bis(hydroxymethyl)-5,29-diisobutyl-26,32-diisopropyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontane-1,44-dioic acid
ID: ALA3272681
Chembl Id: CHEMBL3272681
Cas Number: 64421-69-8
PubChem CID: 16130992
Max Phase: Preclinical
Molecular Formula: C117H199N41O41
Molecular Weight: 2836.12
Molecule Type: Protein
Associated Items: